Insights

  • Date

  • Content Type

  • Reset

Blog

Navigating the complex and evolving regulatory environment of 3D Printing

20.09.22

By Elena Meurer

Interest in manufacturing solutions that utilize 3D printing technology is constantly growing. Recently, 3D printing
Read More

Blog

On the acceleration of gene editing: what’s next?

20.09.22

By Tim Farries, PhD

A timely panel debate is coming, and Biopharma Excellence will be privileged to moderate it,
Read More

Blog

Getting the balance right with biosimilars

16.05.22

By Peter Lavrencic

As many of the top-selling biotech drugs face loss of patent in the next few years, a large number...
Read More

Blog

A Meeting of Minds: Cell & Gene Conference Brings Tight-Knit Community Together

16.05.22

By Emma Cheesman-Ungstrup | Liron Sarid-Krebs | Elena Meurer

After two years stuck at home and only able to attend virtual conferences, the 2022 Cell & Gene Meeting...
Read More

Blog

The dos and don’ts of scientific due diligence

12.04.22

By Dr. Diane Seimetz

Partnering, mergers and acquisitions, and product licensing require careful preparation, particularly when it comes to
Read More

Blog

The Risk-Reward Conundrum

30.03.22

By Dr. Diane Seimetz

Opportunities and challenges of bringing innovative therapies to market.

Read More